Impact of initial rhythm control with cryoballoon ablation versus drug therapy on atrial fibrillation recurrence and quality of life: results from the Cryo-FIRST study

Back

EHRA Premium Access

Impact of initial rhythm control with cryoballoon ablation versus drug therapy on atrial fibrillation recurrence and quality of life: results from the Cryo-FIRST study

Session: Treatment and prognosis of atrial fibrillation

Topic: Rhythm Control, Catheter Ablation

Speaker: Doctor N. Pavlovic (Zagreb, HR)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Nikola Pavlovic

University Hospital Dubrava, Zagreb (Croatia)

3 presentations

1 follower

5 more presentations in this session

Early rhythm-control ablation therapy in preventing AF recurrences: insight from the CHARISMA Registry

Speaker: Doctor L. Segreti (Pisa, IT)

Prognosis of new-onset of atrial fibrillation in acute coronary syndrome: Portuguese experience

Speaker: Doctor H. Santos (Lisboa, PT)

Efficacy and safety of 50-60 Watt high-power short-duration radiofrequency catheter ablation of atrial fibrillation: A propensity score matching study

Speaker: Doctor J. Park (Yongin, KR)

Endocardial left atrial appendage occlusion in atrial fibrillation: computational fluid dynamics simulations to assess stroke risk

Speaker: Associate Professor C. Corsi (Bologna, IT)

Left atrial strain imaging evaluation: a strong predictor of atrial fibrillation recurrence after single-procedure catheter ablation

Speaker: Doctor P. Garcia Bras (Lisbon, PT)

Access the full session

Treatment and prognosis of atrial fibrillation

Speakers: Doctor N. Pavlovic, Doctor L. Segreti, Doctor H. Santos, Doctor J. Park, Associate Professor C. Corsi...

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources